Mexican chef creates $25,000 taco — but no takers yet

1 / 4
This undated handout photo released by Grand Velas Los Cabos Resort on March 7, 2017 shows the most expensive “taco” in the world in Los Cabos, Baja California, Mexico. The taco, which is prepared by the resort’s chef with corn tortilla, golden flakes, shrimps, Kobe meat, Beluga caviar, black truffle, Brie cheese and a special hot sauce, costs 25.000 US dollars. (AFP)
2 / 4
This undated handout photo released by Grand Velas Los Cabos Resort on March 7, 2017 shows the most expensive “taco” in the world in Los Cabos, Baja California, Mexico. The taco, which is prepared by the resort’s chef with corn tortilla, golden flakes, shrimps, Kobe meat, Beluga caviar, black truffle, Brie cheese and a special hot sauce, costs 25.000 US dollars. (AFP)
3 / 4
This undated handout photo released by Grand Velas Los Cabos Resort on March 7, 2017 shows the most expensive “taco” in the world in Los Cabos, Baja California, Mexico. The taco, which is prepared by the resort’s chef with corn tortilla, golden flakes, shrimps, Kobe meat, Beluga caviar, black truffle, Brie cheese and a special hot sauce, costs 25.000 US dollars. (AFP)
4 / 4
This undated handout photo released by Grand Velas Los Cabos Resort on March 7, 2017 shows the most expensive “taco” in the world in Los Cabos, Baja California, Mexico. The taco, which is prepared by the resort’s chef with corn tortilla, golden flakes, shrimps, Kobe meat, Beluga caviar, black truffle, Brie cheese and a special hot sauce, costs 25.000 US dollars. (AFP)
Updated 09 March 2017
0

Mexican chef creates $25,000 taco — but no takers yet

MEXICO CITY: Shrimp, caviar, truffle and gold flakes aren’t standard ingredients in Mexico’s popular tacos. But chef Juan Licerio Alcala uses them to create the world’s most expensive taco at $25,000.
No one has ordered one. Yet.
The handheld dish made of a corn or wheat tortilla folded around a filling is low-cost fare in Mexico.
Licerio, the chef at the Grand Velas Los Cabos Resort, a luxury vacation destination in Baja California, told AFP he decided to think outside the box.
“People are excited and a little surprised about how you can eat a taco for $25,000 (497,000 pesos) when you can find one on the street for 10 pesos,” he said.
“Then I explain the delicacy, the technique and the harmony that they will lift from the plate, and that it’s worth it.”
To make the over-the-top dish, the chef takes a corn tortilla speckled with 24 carat gold flakes and fills it with Kobe beef, shrimp, Almas Beluga caviar and black truffle Brie cheese.
The taco is dressed with a salsa based on Morita chiles and civet coffee, a pricey liquid made from the fermented droppings of a civet which has eaten the berries of a coffee plant.
For good measure, gold flakes are sprinkled on top.
A week after the outrageously pricey dish hit the menu, no one has ordered it, the chef admitted.
But he said many have shown interest, mostly US customers who like to “push the boundaries.”
Ordering the world’s most expensive taco has its own particular method. First, a customer has to put down a $12,500 deposit and already be staying in the presidential suite.
The dish is presented in the middle of the desert encircled by motorcycles, or during a marriage proposal.
“We can adjust to the guest,” Licerio said.
If money is no object, the chef has just the tipple to complement the taco: the luxury tequila Pasion Azteca, at $150,000 a bottle.


Jazz Pharma’s sleep disorder treatment gets US FDA nod

Updated 21 March 2019
0

Jazz Pharma’s sleep disorder treatment gets US FDA nod

  • The drug, solriamfetol, will treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea
  • The patent of Jazz's narcolepsy drug, Xyrem, were declared invalid by a US appeals court in July
The US Food and Drug Administration approved Jazz Pharmaceuticals Plc’s treatment for patients with a form of sleep disorder, the company said on Wednesday.
The drug, solriamfetol, will treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA).
Solriamfetol is expected to be commercially available in the United States following the final scheduling decision by the Drug Enforcement Administration (DEA), Jazz said in a statement.
The approval comes as Jazz is trying to reduce its reliance on its blockbuster narcolepsy drug, Xyrem, whose patents were declared invalid by a US appeals court in July.
Xyrem is an approved treatment for excessive daytime sleepiness and cataplexy in patients with narcolepsy. It brought in sales of $1.4 billion in 2018 and accounted for about 70 percent of company’s revenue.
“Jazz is trying to reduce its reliance on Xyrem, and solriamfetol will be one of the drugs it plans to launch to do that,” Mizuho Securities USA analyst Irina Koffler said ahead of the agency’s decision.
“Solriamfetol is expected to be an important driver of both diversification and growth,” RBC Capital Markets analyst Randall Stanicky said in a note ahead of the approval.
Solriamfetol is expected to bring in revenue of $314 million by 2024, Stanicky said.
Narcolepsy is a chronic sleep disorder with overwhelming daytime drowsiness and sudden attacks of sleep, while obstructive sleep apnea is a potentially serious sleep disorder that can cause breathing to repeatedly stop and start.
“Narcolepsy is very disabling to people as they often get diagnosed young and stop their education and drop out of high school or college,” Koffler said.
“Sleep apnea is a different problem in the sense that a lot of people don’t know they have it, have trouble breathing at night and they even fall asleep during the day.”